LaserBand signs an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems

LaserBand, the leading provider of patient identification wristbands and related products, recently signed an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems, one of the nation’s largest group purchasing organizations (GPO). Under the terms of the contract, MedAssets will make LaserBand’s wristbands and labels available to its extensive customer base of more than 1,200 hospitals and 30,000 non-acute-care healthcare providers.

LaserBand is unique in its industry, holding twice as many patient identification wristband patents as all competitors combined. No other manufacturer can offer a complete cross-platform product line that works with all existing patient ID technologies and includes water-and alcohol-resistant, self-laminating wristbands, for maximum protection of critical patient data. In addition, LaserBand offers both laser-printed and thermal-printed wristbands for compatibility with existing technology.

In announcing the agreement, LaserBand President and CEO Sanjay Jain said, “LaserBand products are used to protect millions of patients worldwide each year, largely due to our commitment to mistake-free patient care, our unparalleled research and development program, and our focus on building strong customer relationships. LaserBand’s new partnership with MedAssets has the potential to extend the benefits of improved safety and comfort to millions more patients in healthcare facilities across the United States.”

The new agreement is expected to ease implementation and improve workflow of MedAssets members’ patient identification processes while improving the safety and comfort of patients. Also, MedAssets member facilities will continue to enhance their operating margins and cash flow by leveraging one of the nation’s largest GPOs. The terms of the contract make LaserBand’s complete line of cross-platform products available to MedAssets’ hospital and IDN GPO customers through December 31, 2012.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare